EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Investigating HLA haplotypes as a potential risk factor for nodding syndrome: A case-control study in the Mahenge area, Tanzania

Amber Hadermann iD, Dan Bhwana, Athanas D Mhina, Luís-Jorge Amaral, Joseph N Siewe Fodjo, Marie-Paule Emonds, Sarah Weckhuysen, Bruno P Mmbando, Robert Colebunders

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012971 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Amber Hadermann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Institute, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Nodding Syndrome, Haplotypes, Genetic Predisposition to Disease, Onchocerciasis. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Flemish University development cooperation, Research Foundation Flanders (FWO), VLIRUOS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nodding syndrome (NS) is a disabling childhood-onset epilepsy occurring in onchocerciasis-endemic regions. High Onchocerca volvulus microfilarial loads in childhood are a key risk factor, but not all heavily infected individuals develop NS, suggesting a possible role for host genetic susceptibility. Human leukocyte antigen (HLA) haplotypes have been implicated in susceptibility to various infectious and autoimmune diseases, including onchocerciasis. We investigated potential associations between HLA haplotypes and onchocerciasis-associated epilepsy (OAE), including NS, in Tanzania.

Methods

A case-control study was conducted in an onchocerciasis-endemic area in the Mahenge area, Tanzania, including 98 persons with epilepsy and 112 controls. DNA was extracted from dry blood spots and HLA sequence-based typing was performed by Histogenetics (Ossining, USA). A total of 11 HLA loci (HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, and -DPB1) were exon sequenced. The HLA-typed dataset was analysed using pyHLA, including Bonferroni as multi-test adjustment, to test for associations with O. volvulus anti-Ov16 seropositivity, epilepsy, OAE and NS.

Results

Anti-Ov16 seropositivity was significantly higher in cases than controls (76.5% vs 58.9%; p = 0.01). No HLA alleles were significantly associated with epilepsy, OAE, NS, or anti-Ov16 seropositivity after correction. Before adjustment, HLA-C07:01 appeared to be a risk factor for epilepsy, HLA-DQB106:02 was associated with OAE, HLA-B35:01 with NS, and HLA-C08:02 and DRB1*03:01 with anti-Ov16 seropositivity. Post-hoc power analysis indicated that substantially larger sample sizes would be required to confirm these associations.

Conclusions

This study did not identify statistically significant HLA associations with epilepsy, OAE, NS, or O. volvulus exposure. However, several alleles—particularly HLA-B*35:01, also reported in a previous South Sudanese study—emerged as potential candidates for further investigation. Larger, multi-country studies with sufficient power are needed to clarify whether host genetic factors contribute to susceptibility to OAE and NS. Strengthening onchocerciasis elimination programmes remains essential, as NS is a preventable disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nodding SyndromeHaplotypesGenetic Predisposition to DiseaseOnchocerciasisHLA AntigensHumansTanzaniaCase-Control StudiesMaleFemaleChildRisk FactorsAdolescentChild, PreschoolYoung AdultAdultOnchocerca volvulus

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Global Health Institute, University of Antwerp, Antwerp, Belgium.
  • National Institute for Medical Research, Tanga Research, Tanga, Tanzania.
  • Histocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.
  • Department of Neurology, University Hospital Antwerp, Belgium.
  • VIB-Center for Molecular Neurology, VIB, University of Antwerp, Belgium.
  • Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Amber Hadermann

Förderung

  • Flemish University development cooperation
  • Research Foundation Flanders (FWO)
  • VLIRUOS
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Hadermann, A., Bhwana, D., Mhina, A. D., Amaral, L. J., Siewe Fodjo, J. N., Emonds, M. P., Weckhuysen, S., Mmbando, B. P., & Colebunders, R. (2025). Investigating HLA haplotypes as a potential risk factor for nodding syndrome: A case-control study in the Mahenge area, Tanzania. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012971

Vancouver

Hadermann A, Bhwana D, Mhina AD, Amaral LJ, Siewe Fodjo JN, Emonds MP, et al. Investigating HLA haplotypes as a potential risk factor for nodding syndrome: A case-control study in the Mahenge area, Tanzania. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012971

BibTeX
@article{Hadermann2025,
  author = {Hadermann, Amber and Bhwana, Dan and Mhina, Athanas D and Amaral, Luís-Jorge and Siewe Fodjo, Joseph N and Emonds, Marie-Paule and Weckhuysen, Sarah and Mmbando, Bruno P and Colebunders, Robert},
  title = {Investigating HLA haplotypes as a potential risk factor for nodding syndrome: A case-control study in the Mahenge area, Tanzania},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012971}
}
Kostenlos starten →